AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00667160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tacrolimus ointment
Description: topical
Study NCT00667160 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pimecrolimus cream
Description: topical
Study NCT02005731 — intervention group
Intervention type: DEVICE
Intervention: Low intensity linear focused shockwave device ('Renova')
Study NCT03393364 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone
Description: Patients receive oxycodone for pain control after outpatient urologic surgery.
Study NCT03393364 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketorolac
Description: Patients receive ketorolac for pain control after outpatient urologic surgery
Study NCT01105416 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Prevention Intervention (BPI)
Description: Brief Prevention Intervention: Participants will receive the BPI, a brief, family-focused prevention intervention in the Pediatric ED. The session will be comprised of parent-targeted skill building directed primarily at parental monitoring and the importance of parent-adolescent communication as the precursor to successful monitoring.
Study NCT01105416 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: ESC
Description: Enhanced standard care
Study NCT00576784 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pioglitazone and glimepiride
Description: switch from any insulin treatment to 30 mg pioglitazone and 3 mg glimepiride.
Study NCT01881035 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Renal nerve denervation
Description: Renal nerve denervation is performed by catheter ablation of renal arteries influencing the sympathetic nerves.
Study NCT02358330 — intervention group
Intervention type: OTHER
Intervention: EHR Enhanced Clinic Intervention
Description: The clinics assigned to the experimental condition will have EHR enhancements introduced.
Study NCT00932139 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture control
Description: First visit, blood pressure monitoring for 60 minutes at rest, then monitoring for subsequent 24 hours to measure BP and heart rate. At next 6-8 visits, Electro-acupuncture (EA) treatment for 30 minutes will be administered. BP and heart rate measurements will be taken 30 minutes before and after EA.
Study NCT00932139 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture test
Description: First visit, blood pressure monitoring for 60 minutes at rest, then monitoring for subsequent 24 hours to measure BP and heart rate. At next 6-8 visits, Electro-acupuncture (EA) treatment for 30 minutes will be administered. BP and heart rate measurements will be taken 30 minutes before and after EA.
Study NCT03956953 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986165
Description: Dose 1 or Dose 2 on Day 1, and from Days 5-19'
Study NCT03956953 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo matching Dose 1 or Dose 2 on Day 1, and from Days 5-19
Study NCT04114942 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Constant Coach
Description: 20 weeks of didactic training and 10 weeks of internship, with coaching throughout.
Study NCT05601076 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: fixed with the triple-buffer system
Description: The steps were as follows: i) elastic cotton tape (3M 2733-25 Japan Ltd., Tokyo, Japan) was used at the proximal 15 cm from the incision, with 5 × 2.5 cm pieces glued to the skin and fixed with the drainage tube using surgical knots; ii) the distal end of the ligation was fixed using the same method, while the ligation position was higher than the first; iii) the ligature point was fixed next to the elastic soft cotton tape (5 × 5 cm), using the high-platform method to fix the drainage tube, with the drainage tube curved; and iv) the drainage tube between the two fixed points was inserted with a specific radian.
Study NCT02145299 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TruePath CTO Device
Description: The TruePath CTO Device is composed of a 0.018 guidewire and a motor housing with a connector cable along with a sterile, disposable battery-powered Control Unit for manipulation of the device during operation. The TruePath CTO Device is indicated to facilitate the intra-luminal placement of conventional guidewires beyond peripheral artery chronic total occlusions.
Study NCT02145299 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CROSSER CTO Device
Study NCT01762293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Famitinib
Description: Famitinib 25 mg p.o. qd
Study NCT01762293 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: p.o. qd
Study NCT02388061 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenecteplase
Study NCT02388061 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tissue Plasminogen Activator
Study NCT05601076 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: fixed using the conventional lifting platform method
Description: In terms of the control group, two lines of flexible cotton tape (3M 2733-25 Japan Ltd., Tokyo, Japan) measuring 10 × 2.5 cm were used, and the drainage tube was fixed parallel to the long axis and glued to the middle-position 360° winding tube once the drainage tube was 0.5 cm higher than the surrounding skin. Next, the drainage tube was fixed at both ends to the patient's skin using adhesive tape. Then, the tube and the adhesive plaster were overlapped vertically and horizontally, the tube was inserted, the adhesive plaster was added, and then the chest tube was fixed on the adhesive plaster by knotting the interspersed cotton rope, which was equal to indirectly fixing the tube on the patient's skin
Study NCT00531362 — intervention group
Intervention type: DRUG
Intervention: Plain aspirin
Description: Plain aspirin 75 mg or 150 mg
Study NCT04105114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buspirone
Description: Oral Buspirone 7.5mg - 10mg daily during the treatment phase.
Study NCT04105114 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive Spinal Cord Stimulation
Description: A non-invasive transcutaneous electrical spinal cord stimulator, which can be used a multiple spinal locations.
Study NCT04105114 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ekso Bionics Exoskeleton
Description: This robotic exoskeleton is designed to assist people with neurological injuries for balance, standing, and stepping overground.
Study NCT04105114 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gravity Neutral Device
Description: This device is used to train and assess non-weight bearing stepping movements. When using the device, participants will be lying on their side with their legs suspended off the end of a table supported by small slings that are anchored securely to the apparatus.
Study NCT04105114 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Body Weight Supported Treadmill Training
Description: Participants will be supported by a special harness while they are stepping on a treadmill. Trained technicians or therapists will be assist the trunk and legs during stepping as needed.
Study NCT04105114 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rolling Walker
Description: A standard rolling walker will be used for balance support and stability during stepping overground.
Study NCT02656251 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.12% Clorhexidine with alcohol
Description: Use of 0.12% Clorhexidine with alcohol every 12 hours for 04 days
Study NCT02656251 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.12% Clorhexidine with alcohol
Description: Use of 0.12% Clorhexidine with alcohol every 12 hours for 04 days
Study NCT02656251 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.12% Clorhexidine with alcohol
Description: Use of 0.12% Clorhexidine with alcohol every 12 hours for 04 days
Study NCT02656251 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Description: Use of placebo every 12 hours for 04 days
Study NCT02656251 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo
Description: Use of placebo every 12 hours for 04 days
Study NCT02656251 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Use of placebo every 12 hours for 04 days
Study NCT02656251 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.12% Clorhexidine without alcohol
Description: Use of 0.12% Clorhexidine without alcohol, every 12 hours for 04 days
Study NCT02656251 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.12% Clorhexidine without alcohol
Description: Use of 0.12% Clorhexidine without alcohol, every 12 hours for 04 days
Study NCT02656251 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.12% Clorhexidine without alcohol
Description: Use of 0.12% Clorhexidine without alcohol, every 12 hours for 04 days
Study NCT03381196 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pimodivir 600 mg
Description: Participants will receive pimodivir 600 mg, orally, twice daily, for 5 days (on Days 1 through 5; for participants who will receive only 1 dose of pimodivir on Day 1 \[evening\], dosing will continue until the morning of Day 6).
Study NCT01884454 — intervention group
Intervention type: BEHAVIORAL
Intervention: Sleep deprivation
Description: Volunteers will be submitted to total sleep deprivation (SD) or selective REM sleep deprivation for 48 hours. After SD, these volunteers will be allowed to sleep for 48 hours (period rebound).
Study NCT01952145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: insulin degludec/liraglutide
Description: Insulin degludec/liraglutide is injected subcutaneously s.c. (under the skin) once daily (OD). Dose individually adjusted. Subjects should continue their pre-trial treatment with metformin.
Study NCT01952145 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: insulin glargine
Description: Insulin glargine is injected subcutaneously s.c. (under the skin) once daily (OD). Dose individually adjusted. Subjects should continue their pre-trial treatment with metformin.
Study NCT02752035 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gilteritinib
Description: Tablet, oral
Study NCT02752035 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: azacitidine
Description: Subcutaneous injection or intravenous infusion
Study NCT02752035 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: azacitidine
Description: Subcutaneous injection or intravenous infusion
Study NCT06638476 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Perturbation Induced Step training
Description: A sudden lateral displacement of the treadmill.
Study NCT06638476 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Voluntary step training
Description: Voluntary steps emphasizing speed, movement of center of mass and taking larger steps.
Study NCT03359772 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesthetic Ability Trainer
Description: Kinesthetic Ability Trainer
Study NCT02026167 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collaborative Care
Description: Addition of a Health Care Assistant to treatment team, case review by expert panel of supervisors, non-medical interventions
Study NCT01462747 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: KULIST
Description: Twice daily dosing for 8 weeks
Study NCT02304159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: daclatasvir
Study NCT00178633 — intervention group
Intervention type: PROCEDURE
Intervention: Bariatric surgery
Description: Bariatric surgery was not part of this trial. This was observational trial of persons post-bariatric surger.
Study NCT00310167 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiation therapy
Study NCT02304159 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: daclatasvir
Study NCT02304159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sofosbuvir, Sovaldi
Study NCT02304159 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sofosbuvir, Sovaldi
Study NCT02304159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribavirin
Study NCT02304159 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ribavirin
Study NCT04466839 — intervention group
Intervention type: OTHER
Intervention: Questionnaire and interview
Description: The questionnaires are Parkinson Disease Questionnaire-8 Items (PDQ-8) Visual Analog Scale (VAS) is visual analog scale visual numeric from 0 to 100, Neuropsychiatric Inventory-Questionnaire-Reduced (NPI-R) and Clinical Global Impression-Impairment (CGI-I).
Study NCT01370044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbogen
Description: 3 minutes administration of carbogen
Study NCT01370044 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 3 minutes administration of oxygen
Study NCT01405664 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Weight-Bearing as Tolerated
Description: WBAT immediately after surgery
Study NCT06061185 — intervention group
Intervention type: DEVICE
Intervention: Multimodal CT
Description: Non-contrast computed tomography, computed tomography angiography and computed tomography perfusion
Study NCT00023595 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CABG surgery plus MED
Description: CABG plus standard medication management for Coronary Artery Disease
Study NCT01864759 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ICOVIR-5
Study NCT00023595 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Active Medication Alone
Description: Standard medication for coronary artery disease and heart failure management.
Study NCT00023595 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CABG plus MED and SVR
Description: H02: the experimental arm receives active medical therapy and CABG and surgical ventricular restoration whereas the control group receives active medical therapy and CABG; for H01: the experimental arm receives active medical therapy and CABG whereas the control group receives active medical therapy alone
Study NCT03257072 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 50 Necator americanus L3 larvae
Description: 1x50 Necator americanus L3 larvae
Study NCT03257072 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 100 Necator americanus L3 larvae
Description: 2x50 Necator americanus L3 larvae
Study NCT01504360 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: tumor genetic predisposition to develop sarcoma assessment
Description: data concerning initial radiation and localisation of the sarcoma secondary developed will be collected. 2 blood samples (2 x 5 ml)will be collected. One sample of 5 mm will be dedicated to study radiation induced apoptosis assessed by flow cytometry. The second sample will be used to study the polymorphism of the genes involved in reparation of DNA by using chip screening of single nucleotide polymorphisms (SNP). DNA will be extracted and controlled by flow cytometrical separation.
Study NCT01504360 — intervention group
Intervention type: GENETIC
Group type: ACTIVE_COMPARATOR
Intervention: tumor genetic predisposition to develop sarcoma assessment
Description: data concerning initial radiation and data demonstrating the lack of secondary sarcoma will be collected . 2 blood samples (2 x 5 ml)will be collected. One sample of 5 mm will be dedicated to study radiation induced apoptosis assessed by flow cytometry. The second sample will be used to study the polymorphism of the genes involved in reparation of DNA by using chip screening of single nucleotide polymorphisms (SNP). DNA will be extracted and controlled by flow cytometrical separation.
Study NCT04611243 — intervention group
Intervention type: BIOLOGICAL
Intervention: third dose vaccination with CoronaVac vaccine
Description: Healthy individuals with low antibody levels after 2 doses of CoronaVac vaccine to receive one additional dose of CoronaVac vaccine
Study NCT04611243 — intervention group
Intervention type: BIOLOGICAL
Intervention: third dose vaccination with BionTech vaccine
Description: Healthy individuals with low antibody levels after 2 doses of CoronaVac vaccine to receive one additional dose of BionTech vaccine
Study NCT04611243 — intervention group
Intervention type: BIOLOGICAL
Intervention: Vaccination with Coronavac vaccine
Description: Healthy individuals to receive Coronavac vaccine 2 doses, 21 days apart
Study NCT04611243 — intervention group
Intervention type: BIOLOGICAL
Intervention: Vaccination with BionTech Vaccine
Description: Healthy individuals to receive BionTech vaccine 2 doses, 21 days apart
Study NCT03490240 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BIPAMS
Description: The primary content of the website is delivered through interactive video courses. The interactive video courses are released seven times during the first two months, four times during the second two months, and twice during the final two months of the intervention.~Another key part of the website is the Tracker feature. This feature allows for tracking of daily step counts (via Yamax SW-200 pedometer) as well as setting goals and monitoring progress over the program.~The one-on-one video chats are conducted face to face through skype and are semi-scripted. The chats consist of an ongoing review of goal-setting and progress toward goal attainment through Tracker as well as discussion of strategies and facilitators of behavioral change based on SCT and current website content. The chats occur seven times during the first two months, four times during the second two months, and twice during the final two months of the intervention.
Study NCT03490240 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: WELLMS
Description: The control condition focuses on self-managing MS through means other than physical activity. The materials are transformations of brochures provided by the NMSS, including Gait or Walking Problems: The Basic Facts; MS and Your Emotions; Pain: The Basic Facts; Solving Cognitive Problems; Taming Stress in MS; Food for Thought: MS and Nutrition; and Vitamins, Minerals, and Herbs: An Introduction. The delivery of the Internet materials and chat sessions will occur on the same time schedule and frequency as the intervention condition, and will have a comparable time commitment. The control condition will account for attention and social contact as well as other possible biases such as initial reactivity and time spent on the website and video chats. The participants in the control condition will not be offered the behavioral intervention for increasing physical activity after completion of the study procedures.
Study NCT02891356 — intervention group
Intervention type: DEVICE
Intervention: DEXA
Description: The Dual Energy X-ray Absorptiometry (DEXA) is a third generation multi-captor DEXA device that allow short duration measurements. It measures Bone Mineral Density (BMD) at the spine and the femoral neck
Study NCT05651490 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Problem Solving Treatment for Diabetes
Description: In the introductory session, the structure of and rationale behind PST-D will be explained. The specialist will work with the participant to develop a problem list related to diabetes self-management and smoking cessation, if applicable.~During the weekly sessions, the participant will be taught and guided through the seven steps of problem solving:~1. Clarifying and defining the problem~2. Setting a realistic goal~3. Brainstorming multiple solutions~4. Generating pros and cons for each solution~5. Evaluating and choosing a preferred solution~6. Developing a specific action plan to implement the solution~7. Evaluating outcomes from the previous session.~Participants will also plan to engage in at least 1 enjoyable activity daily during the week.~The number of sessions will differ based on the specialist's assessment of the participant's problem-solving skills.~Maintenance sessions will be delivered monthly across 3 months in order to follow-up with participants.
Study NCT05651490 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention Control Group
Description: During the sessions, the healthcare practitioners will provide general information and recommendations on general health topics such as oral health, hearing loss, sleep, dementia, adult vaccination, influenza, and dengue fever. Participants will also be given handouts adapted from government agencies and/or public bodies, such as HealthHub, National Health Service, National Addictions Management Service, and National Environmental Agency, on these topics. The healthcare practitioners will avoid discussing topics related to diabetes, diet, physical activity, and medication.
Study NCT03070665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Description: Increasing blood pressure up to 150mmHg for 5min using norepinephrine pump as initial dose 0.05μg/Kg.min during ESD operation, meanwhile check out the potential hemorrhage spot which is not obvious and then use the hot biopsy forceps to coagulate the bleeding spot, after that withdraw the norepinephrine and record the potential bleeding spot's location. The other procedures are the same as control groups'.
Study NCT01379690 — intervention group
Intervention type: OTHER
Intervention: HBA1C
Description: Used level of HBA1C as a reflection of glycaemic control of the cases and controls
Study NCT04417530 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AU-011
Description: AU-011 Via Suprachoroidal Administration with laser treatment
Study NCT04417530 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Suprachoroidal Microinjector
Description: Suprachoroidal Injection Device
Study NCT00310167 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy